PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
1.100
+0.010 (0.92%)
Jun 9, 2026, 10:14 AM EDT - Market open
PMV Pharmaceuticals Market Cap
PMV Pharmaceuticals has a market cap or net worth of $58.66 million as of June 9, 2026. Its market cap has increased by 25.46% in one year.
Market Cap
58.66M
Enterprise Value
-35.13M
1-Year Change
25.46%
Ranking
Category
Stock Price
$1.10
Market Cap Chart
Since the IPO on September 25, 2020, PMV Pharmaceuticals's market cap has decreased from $1.61B to $58.66M, a decrease of -96.36%. That is a compound annual growth rate of -44.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 58.13M | -12.61% |
| Dec 31, 2025 | 66.51M | -14.88% |
| Dec 31, 2024 | 78.14M | -50.73% |
| Dec 29, 2023 | 158.59M | -60.08% |
| Dec 30, 2022 | 397.29M | -62.10% |
| Dec 31, 2021 | 1.05B | -61.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MediciNova | 64.48M |
| Seres Therapeutics | 64.20M |
| TScan Therapeutics | 64.17M |
| Filana Therapeutics | 63.77M |
| ImageneBio | 63.73M |
| Acrivon Therapeutics | 61.21M |
| Impact BioMedical | 61.12M |
| Cingulate | 59.68M |